{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:24:20Z","timestamp":1793892260578,"version":"4.8.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001642"],"award-info":[{"award-number":["82001642"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Selecting an appropriate and personalized Gn starting dose (GSD) is an essential procedure for determining the quality and quantity of oocytes in the controlled ovarian stimulation (COS) process of the in-vitro fertilization (IVF) treatment cycle. The current approach for determining the GSD is mainly based on the experience of a clinician, lacking unified and scientific standards. This study aims to establish a prediction model of GSD, based on which good COS outcomes can be achieved with the influencing factors comprehensively evaluated quantitatively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material and methods<\/jats:title>\n                <jats:p>We collected a total of 1555 patients undergoing the first oocytes retrieving cycle and conducted correlation analysis to find the significant factors related to the GSD. Two GSD models are built based on two popular machine learning approaches, and the one with better model performance is selected as the final model. Finally, clinical application and validation were conducted to verify the effectiveness of the proposed model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>(1) Age, duration of infertility, type of infertility, body mass index (BMI), antral follicle count (AFC), basal follicle stimulating hormone (bFSH), estradiol (E<jats:sub>2<\/jats:sub>), luteinizing hormone (LH), anti-M\u00fcllerian hormone (AMH) and COS treatment regimen were closely related to the GSD (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). (2) The selected model has good modeling performance in terms of both root mean square error (RMSE) (29.87\u2009~\u200934.21) and regression coefficient R (0.947\u2009~\u20090.953). (3) A comprehensive evaluation of influencing factors for GSD is conducted and shows that the top four most significant factors are age, AMH, AFC, and BMI. (4) The proposed GSD can approximate the actual value well in the clinical application, with the mean absolute error of only 11.26 units, and the recommended results can prompt the number of oocytes retrieved (NOR) close to the optimal number.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Modeling the GSD value with machine learning approaches is feasible and effective, and the proposed model has good clinical application for determining the GSD in the IVF treatment cycle.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-022-05152-6","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T07:04:05Z","timestamp":1667545445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Prediction model of gonadotropin starting dose and its clinical application in controlled ovarian stimulation"],"prefix":"10.1186","volume":"22","author":[{"given":"Liang","family":"Hua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Fujin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,4]]},"reference":[{"issue":"1","key":"5152_CR1","doi-asserted-by":"publisher","first-page":"hoz036","DOI":"10.1093\/hropen\/hoz036","volume":"2020","author":"AP Van Montfoort","year":"2020","unstructured":"Van Montfoort AP, Arts EG, Wijnandts L, Sluijmer A, Pelinck M-J, Land JA, Van Echten-Arends J. Reduced oxygen concentration during human IVF culture improves embryo utilization and cumulative pregnancy rates per cycle. Human Reprod Open. 2020;2020(1):hoz036.","journal-title":"Human Reprod Open"},{"issue":"2","key":"5152_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00404-017-4403-z","volume":"296","author":"A Lehner","year":"2017","unstructured":"Lehner A, Kaszas Z, Murber A, Rigo J, Urbancsek J, Fancsovits P. Embryo density may affect embryo quality during in vitro culture in a microwell group culture dish. Arch Gynecol Obstet. 2017;296(2):345\u201353.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"5152_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.31083\/j.ceog4901004","volume":"49","author":"L Liu","year":"2022","unstructured":"Liu L, Liang H, Yang J, Shen F, Li W. Analyzing the detrimental effects of female chronic hepatitis B virus DNA on ovarian reserve function and results of in vitro fertilization. Clin Exp Obstet Gynecol. 2022;49(1):4.","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"6","key":"5152_CR4","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1093\/humrep\/dei499","volume":"21","author":"R Fleming","year":"2006","unstructured":"Fleming R, Deshpande N, Traynor I, Yates RW. Dynamics of FSH-induced follicular growth in subfertile women: relationship with age, insulin resistance, oocyte yield and anti-Mullerian hormone. Human Reprod. 2006;21(6):1436\u201341.","journal-title":"Human Reprod"},{"issue":"10","key":"5152_CR5","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1111\/j.1471-0528.2012.03412.x","volume":"119","author":"A La Marca","year":"2012","unstructured":"La Marca A, Papaleo E, Grisendi V, Argento C, Giulini S, Volpe A. Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles. BJOG. 2012;119(10):1171\u20139.","journal-title":"BJOG"},{"issue":"6","key":"5152_CR6","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.3390\/jcm9061914","volume":"9","author":"A Revelli","year":"2020","unstructured":"Revelli A, Gennarelli G, Biasoni V, Chiad\u00f2 A, Carosso A, Evangelista F, Paschero C, Filippini C, Benedetto C. The ovarian sensitivity index (OSI) significantly correlates with ovarian reserve biomarkers, is more predictive of clinical pregnancy than the total number of oocytes, and is consistent in consecutive IVF cycles. J Clin Med. 2020;9(6):1914.","journal-title":"J Clin Med"},{"issue":"3","key":"5152_CR7","doi-asserted-by":"publisher","first-page":"hox018","DOI":"10.1093\/hropen\/hox018","volume":"2017","author":"O Rustamov","year":"2017","unstructured":"Rustamov O, Wilkinson J, La Marca A, Fitzgerald C, Roberts SA. How much variation in oocyte yield after controlled ovarian stimulation can be explained? A multilevel modelling study. Human Reprod Open. 2017;2017(3):hox018.","journal-title":"Human Reprod Open"},{"issue":"7","key":"5152_CR8","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1093\/humrep\/der106","volume":"26","author":"SK Sunkara","year":"2011","unstructured":"Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod. 2011;26(7):1768\u201374.","journal-title":"Hum Reprod"},{"issue":"5","key":"5152_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1185\/030079906X104678","volume":"22","author":"C Howles","year":"2006","unstructured":"Howles C, Saunders H, Alam V, Engrand P, Panel FTGC. Predictive factors and a corresponding treatment algorithm for controlled ovarian stimulation in patients treated with recombinant human follicle stimulating hormone (follitropin alfa) during assisted reproduction technology (ART) procedures. An analysis of 1378 patients. Curr Med Res Opin. 2006;22(5):907\u201318.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"5152_CR10","doi-asserted-by":"publisher","first-page":"398","DOI":"10.2174\/138920112799361972","volume":"13","author":"A La Marca","year":"2012","unstructured":"La Marca A, Argento C, Sighinolfi G, Grisendi V, Carbone M, D\u2019Ippolito G, Carducci Artenisio A, Stabile G, Volpe A. Possibilities and limits of ovarian reserve testing in ART. Curr Pharm Biotechnol. 2012;13(3):398\u2013408.","journal-title":"Curr Pharm Biotechnol"},{"issue":"10","key":"5152_CR11","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1111\/aogs.13664","volume":"98","author":"JA Leijdekkers","year":"2019","unstructured":"Leijdekkers JA, van Tilborg TC, Torrance HL, Oudshoorn SC, Brinkhuis EA, Koks CAM, Lambalk CB, de Bruin JP, Fleischer K, Mochtar MH, et al. Do female age and body weight modify the effect of individualized FSH dosing in IVF\/ICSI treatment? A secondary analysis of the OPTIMIST trial. Acta Obstet Gynecol Scand. 2019;98(10):1332\u201340.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"8","key":"5152_CR12","first-page":"CD010537","volume":"8","author":"C Farquhar","year":"2018","unstructured":"Farquhar C, Marjoribanks J. Assisted reproductive technology: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2018;8(8):CD010537.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"5152_CR13","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/humrep\/deg181","volume":"18","author":"B Popovic-Todorovic","year":"2003","unstructured":"Popovic-Todorovic B, Loft A, Lindhard A, Bangsb\u00f8ll S, Andersson A, Andersen AN. A prospective study of predictive factors of ovarian response in \u2018standard\u2019IVF\/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram. Hum Reprod. 2003;18(4):781\u20137.","journal-title":"Hum Reprod"},{"issue":"3","key":"5152_CR14","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.rbmo.2014.11.013","volume":"30","author":"F Olivennes","year":"2015","unstructured":"Olivennes F, Trew G, Borini A, Broekmans F, Arriagada P, Warne D, Howles C. Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa. Reprod Biomed Online. 2015;30(3):248\u201357.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"5152_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00404-019-05156-2","volume":"300","author":"M Zhu","year":"2019","unstructured":"Zhu M, Wang S, Yi S, Huang X, Meng J, Chen L, Sun H, Zhou J. A predictive formula for selecting individual FSH starting dose based on ovarian reserve markers in IVF\/ICSI cycles. Arch Gynecol Obstet. 2019;300(2):441\u20136.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"5152_CR16","first-page":"40","volume":"11","author":"JB Scheffer","year":"2017","unstructured":"Scheffer JB, Scheffer BB, de Carvalho RF, Rodrigues J, Grynberg M, Mendez Lozano DH. Age as A Predictor of Embryo Quality Regardless of The Quantitative Ovarian Response. Int J Fertil Steril. 2017;11(1):40\u20136.","journal-title":"Int J Fertil Steril"},{"issue":"13","key":"5152_CR17","doi-asserted-by":"publisher","first-page":"17137","DOI":"10.18632\/aging.203032","volume":"13","author":"S Yan","year":"2021","unstructured":"Yan S, Jin W, Ding J, Yin T, Zhang Y, Yang J. Machine-intelligence for developing a potent signature to predict ovarian response to tailor assisted reproduction technology. Aging. 2021;13(13):17137\u201354.","journal-title":"Aging"},{"issue":"1","key":"5152_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12958-021-00862-6","volume":"19","author":"Y Yang","year":"2021","unstructured":"Yang Y, Liu B, Wu G, Yang J. Exploration of the value of progesterone and progesterone\/estradiol ratio on the hCG trigger day in predicting pregnancy outcomes of PCOS patients undergoing IVF\/ICSI: a retrospective cohort study. Reproductive biology and endocrinology\u202f: RB&E. 2021;19(1):184.","journal-title":"Reproductive biology and endocrinology : RB&E"},{"issue":"7","key":"5152_CR19","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s10815-019-01498-7","volume":"36","author":"P Vogiatzi","year":"2019","unstructured":"Vogiatzi P, Pouliakis A, Siristatidis C. An artificial neural network for the prediction of assisted reproduction outcome. J Assist Reprod Genet. 2019;36(7):1441\u20138.","journal-title":"J Assist Reprod Genet"},{"issue":"7","key":"5152_CR20","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1007\/s10815-021-02123-2","volume":"38","author":"CM Louis","year":"2021","unstructured":"Louis CM, Erwin A, Handayani N, Polim AA, Boediono A, Sini I. Review of computer vision application in in vitro fertilization: the application of deep learning-based computer vision technology in the world of IVF. J Assist Reprod Genet. 2021;38(7):1627\u201339.","journal-title":"J Assist Reprod Genet"},{"key":"5152_CR21","unstructured":"Merican ZZ, Yusof UK, Abdullah NL. Review on embryo selection based on morphology using machine learning methods. Int J Adv Soft Comput Appl. 2021;13(2):44\u201359."},{"key":"5152_CR22","doi-asserted-by":"crossref","unstructured":"Liu L, Shen F, Liang H, Yang Z, Yang J, Chen J. Machine learning-based modeling of ovarian response and the quantitative evaluation of comprehensive impact features. Diagnostics (Basel). 2022;12(2):492\u2013504.","DOI":"10.3390\/diagnostics12020492"},{"issue":"3","key":"5152_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.rbmo.2015.06.001","volume":"31","author":"Pouly JL, Olivennes F, Massin N, Celle M, Caizergues N, Contard F, Group FCS","year":"2015","unstructured":"Pouly JL, Olivennes F, Massin N, Celle M, Caizergues N, Contard F, Group FCS. Usability and utility of the CONSORT calculator for FSH starting doses: a prospective observational study. Reprod Biomed Online. 2015;31(3):347\u201355.","journal-title":"Reprod Biomed Online"},{"issue":"10","key":"5152_CR24","first-page":"5","volume":"25","author":"S Liu","year":"2016","unstructured":"Liu S, Shi J. Relationship between ovarian reserve & response and women age. J Reprod Med. 2016;25(10):5.","journal-title":"J Reprod Med"},{"issue":"6","key":"5152_CR25","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1210\/jcem-65-6-1231","volume":"65","author":"SJ Richardson","year":"1987","unstructured":"Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab. 1987;65(6):1231\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"5152_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/1933719114549856","volume":"22","author":"A Iwase","year":"2015","unstructured":"Iwase A, Nakamura T, Nakahara T, Goto M, Kikkawa F. Anti-M\u00fcllerian hormone and assessment of ovarian reserve after ovarian toxic treatment: a systematic narrative review. Reprod Sci. 2015;22(5):519\u201326.","journal-title":"Reprod Sci"},{"issue":"1","key":"5152_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/humupd\/dmq034","volume":"17","author":"S Broer","year":"2011","unstructured":"Broer S, Dolleman M, Opmeer B, Fauser B, Mol B, Broekmans F. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update. 2011;17(1):46\u201354.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"5152_CR28","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/humrep\/del435","volume":"22","author":"M McIlveen","year":"2007","unstructured":"McIlveen M, Skull J, Ledger W. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population. Hum Reprod. 2007;22(3):778\u201385.","journal-title":"Hum Reprod"},{"issue":"4","key":"5152_CR29","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.rbmo.2013.07.008","volume":"27","author":"VTN Lan","year":"2013","unstructured":"Lan VTN, Linh NK, Tuong HM, Wong P, Howles CM. Anti-M\u00fcllerian hormone versus antral follicle count for defining the starting dose of FSH. Reprod Biomed Online. 2013;27(4):390\u20139.","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"5152_CR30","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1210\/clinem\/dgac039","volume":"107","author":"MI Cedars","year":"2022","unstructured":"Cedars MI. Evaluation of Female Fertility-AMH and Ovarian Reserve Testing. J Clin Endocrinol Metab. 2022;107(6):1510\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"5152_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.repbio.2016.12.002","volume":"17","author":"K Keane","year":"2017","unstructured":"Keane K, Cruzat VF, Wagle S, Chaudhary N, Newsholme P, Yovich J. Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome. Reprod Biol. 2017;17(1):51\u20139.","journal-title":"Reprod Biol"},{"issue":"6","key":"5152_CR32","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.fertnstert.2014.08.013","volume":"102","author":"J-C Arce","year":"2014","unstructured":"Arce J-C, Andersen AN, Fern\u00e1ndez-S\u00e1nchez M, Visnova H, Bosch E, Garc\u00eda-Velasco JA, Barri P, De Sutter P, Klein BM, Fauser BC. Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antim\u00fcllerian hormone\u2013stratified, dose\u2013response trial in women undergoing in vitro fertilization\/intracytoplasmic sperm injection. Fertil Steril. 2014;102(6):1633-1640. e1635.","journal-title":"Fertil Steril"},{"issue":"1","key":"5152_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/humrep\/deh044","volume":"19","author":"HJ Out","year":"2004","unstructured":"Out HJ, Rutherford A, Fleming R, Tay CC, Trew G, Ledger W, Cahill D. A randomized, double-blind, multicentre clinical trial comparing starting doses of 150 and 200 IU of recombinant FSH in women treated with the GnRH antagonist ganirelix for assisted reproduction. Hum Reprod. 2004;19(1):90\u20135.","journal-title":"Hum Reprod"},{"issue":"12","key":"5152_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189830","volume":"12","author":"SL Loy","year":"2017","unstructured":"Loy SL, Cheung YB, Fortier MV, Ong CL, Tan HH, Nadarajah S, Chan JKY, Viardot-Foucault V. Age-related nomograms for antral follicle count and anti-Mullerian hormone for subfertile Chinese women in Singapore. PLoS ONE. 2017;12(12): e0189830.","journal-title":"PLoS ONE"},{"key":"5152_CR35","first-page":"Cd001299","volume":"2","author":"S Daya","year":"2000","unstructured":"Daya S. Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles. Cochrane Database Syst Rev. 2000;2:Cd001299.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"5152_CR36","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3109\/14647273.2013.795385","volume":"16","author":"LG Nardo","year":"2013","unstructured":"Nardo LG, Bosch E, Lambalk CB, Gelbaya TA. Controlled ovarian hyperstimulation regimens: a review of the available evidence for clinical practice. Produced on behalf of the BFS Policy and Practice Committee. Hum Fertil (Camb). 2013;16(3):144\u201350.","journal-title":"Hum Fertil (Camb)"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-05152-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-022-05152-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-05152-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T07:05:06Z","timestamp":1667545506000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-022-05152-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,4]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5152"],"URL":"https:\/\/doi.org\/10.1186\/s12884-022-05152-6","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,4]]},"assertion":[{"value":"9 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Medical Ethics Committee of Renmin Hospital of Wuhan University (Approval number WDRY2019-K077, 26 November 2019). Informed consent has been obtained from all the patients involved in this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"810"}}